2025 Q4 -tulosraportti
76 päivää sitten
‧39 min
Tarjoustasot
Spotlight Stock Market DK
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 50 | NON | AVA | ||
| 131 | SSWM | NON | ||
| 618 | NRD | NON | ||
| 82 | NON | NON | ||
| 1 557 | DDB | NON |
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Danske Bank A/S | 2 000 | 600 | +1 400 | 0 |
| Nordea Bank Abp | 1 024 | 0 | +1 024 | 0 |
| Avanza Bank AB | 599 | 50 | +549 | 0 |
| SSW Market Making GmbH | 3 100 | 2 969 | +131 | 0 |
| Nordnet Bank AB | 22 167 | 25 271 | −3 104 | 18 548 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Nordnet Bank AB | 22 167 | 25 271 | −3 104 | 18 548 |
| SSW Market Making GmbH | 3 100 | 2 969 | +131 | 0 |
| Avanza Bank AB | 599 | 50 | +549 | 0 |
| Nordea Bank Abp | 1 024 | 0 | +1 024 | 0 |
| Danske Bank A/S | 2 000 | 600 | +1 400 | 0 |
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 28.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 1.12.2025 | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2025 Q1 -tulosraportti 25.4.2025 | ||
2024 Q4 -tulosraportti 27.2.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·7 t sittenJust now at 6.58 AM, I discovered Curasight. Unfortunately, the description of their work here on Nordnet is completely incomprehensible to a layman due to the unusual technical terms used. I therefore asked AI: “Translate the technical terms describing the work of the Danish biotech company Curasight into language a layman can understand”, and received the following answer: “In short, the work of the Danish biotech company Curasight is about finding and irradiating aggressive cancer cells from within, so that healthy tissue is not damaged. Here are the most important technical terms translated into easily understandable language: The biological target uPAR (biomarker / receptor): A type of "antenna" or biological receiver located on the surface of aggressive cancer cells. Healthy cells largely do not have this antenna. Curasight uses this antenna as a homing address. Ligand (Peptide): A small, specially designed molecule (a protein part) that acts like a key. It can precisely lock onto the uPAR antenna on the cancer cell. The technology and methodTheranostics (Theranostics): A word composed of therapy (treatment) and diagnostics (examination). This means that the company uses exactly the same homing molecule to both visualize the cancer on a scanner and then treat it. Radionuclide therapy / Radioligand therapy (RLT): An integrated radiation treatment. A radioactive substance is attached to the homing molecule (the ligand) and injected into the bloodstream. It seeks out the cancer cells itself and destroys them with short-range radiation from within. PET scan (Positron Emission Tomography): An advanced imaging scan that shows the body's biological activity instead of just the physical organs. Curasight's specific productsuTRACE® (Diagnostics): Curasight's scanning method. Here, the homing molecule is coupled with a mild, radioactive tracer. This causes aggressive cancer tumors to "light up" on a PET scanner, so the doctor can see exactly how severe the cancer is. uTREAT® (Treatment): Curasight's treatment method. Here, the same homing molecule is reused, but now it is equipped with a much more powerful, radioactive substance. It functions as a homing missile that delivers radiation directly into the cancer cell without harming the surrounding healthy tissue.”
·22 t sittenI got a good tip - I thought - and bought, but with a drop of 17 k. it hasn't gone so well so far, and I think it's lying in a straight line and not really moving. Does anyone have an idea where the stock is going, or should I give up and sell?
·1 päivä sittenDoes anyone know if there is a Discord group with Curasight?
·1 päivä sittenYes, it is here. https://discord.gg/XcsdMTJQtK
·2 päivää sittenHow heavily loaded are people here, unfortunately I only have 275 units so far 🫣
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q4 -tulosraportti
76 päivää sitten
‧39 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·7 t sittenJust now at 6.58 AM, I discovered Curasight. Unfortunately, the description of their work here on Nordnet is completely incomprehensible to a layman due to the unusual technical terms used. I therefore asked AI: “Translate the technical terms describing the work of the Danish biotech company Curasight into language a layman can understand”, and received the following answer: “In short, the work of the Danish biotech company Curasight is about finding and irradiating aggressive cancer cells from within, so that healthy tissue is not damaged. Here are the most important technical terms translated into easily understandable language: The biological target uPAR (biomarker / receptor): A type of "antenna" or biological receiver located on the surface of aggressive cancer cells. Healthy cells largely do not have this antenna. Curasight uses this antenna as a homing address. Ligand (Peptide): A small, specially designed molecule (a protein part) that acts like a key. It can precisely lock onto the uPAR antenna on the cancer cell. The technology and methodTheranostics (Theranostics): A word composed of therapy (treatment) and diagnostics (examination). This means that the company uses exactly the same homing molecule to both visualize the cancer on a scanner and then treat it. Radionuclide therapy / Radioligand therapy (RLT): An integrated radiation treatment. A radioactive substance is attached to the homing molecule (the ligand) and injected into the bloodstream. It seeks out the cancer cells itself and destroys them with short-range radiation from within. PET scan (Positron Emission Tomography): An advanced imaging scan that shows the body's biological activity instead of just the physical organs. Curasight's specific productsuTRACE® (Diagnostics): Curasight's scanning method. Here, the homing molecule is coupled with a mild, radioactive tracer. This causes aggressive cancer tumors to "light up" on a PET scanner, so the doctor can see exactly how severe the cancer is. uTREAT® (Treatment): Curasight's treatment method. Here, the same homing molecule is reused, but now it is equipped with a much more powerful, radioactive substance. It functions as a homing missile that delivers radiation directly into the cancer cell without harming the surrounding healthy tissue.”
- ·22 t sittenI got a good tip - I thought - and bought, but with a drop of 17 k. it hasn't gone so well so far, and I think it's lying in a straight line and not really moving. Does anyone have an idea where the stock is going, or should I give up and sell?
- ·1 päivä sittenDoes anyone know if there is a Discord group with Curasight?·1 päivä sittenYes, it is here. https://discord.gg/XcsdMTJQtK
- ·2 päivää sittenHow heavily loaded are people here, unfortunately I only have 275 units so far 🫣
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Spotlight Stock Market DK
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 50 | NON | AVA | ||
| 131 | SSWM | NON | ||
| 618 | NRD | NON | ||
| 82 | NON | NON | ||
| 1 557 | DDB | NON |
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Danske Bank A/S | 2 000 | 600 | +1 400 | 0 |
| Nordea Bank Abp | 1 024 | 0 | +1 024 | 0 |
| Avanza Bank AB | 599 | 50 | +549 | 0 |
| SSW Market Making GmbH | 3 100 | 2 969 | +131 | 0 |
| Nordnet Bank AB | 22 167 | 25 271 | −3 104 | 18 548 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Nordnet Bank AB | 22 167 | 25 271 | −3 104 | 18 548 |
| SSW Market Making GmbH | 3 100 | 2 969 | +131 | 0 |
| Avanza Bank AB | 599 | 50 | +549 | 0 |
| Nordea Bank Abp | 1 024 | 0 | +1 024 | 0 |
| Danske Bank A/S | 2 000 | 600 | +1 400 | 0 |
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 28.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 1.12.2025 | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2025 Q1 -tulosraportti 25.4.2025 | ||
2024 Q4 -tulosraportti 27.2.2025 |
2025 Q4 -tulosraportti
76 päivää sitten
‧39 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q1 -tulosraportti 28.5. |
| Menneet tapahtumat | ||
|---|---|---|
2025 Q4 -tulosraportti 26.2. | ||
2025 Q3 -tulosraportti 1.12.2025 | ||
2025 Q2 -tulosraportti 28.8.2025 | ||
2025 Q1 -tulosraportti 25.4.2025 | ||
2024 Q4 -tulosraportti 27.2.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·7 t sittenJust now at 6.58 AM, I discovered Curasight. Unfortunately, the description of their work here on Nordnet is completely incomprehensible to a layman due to the unusual technical terms used. I therefore asked AI: “Translate the technical terms describing the work of the Danish biotech company Curasight into language a layman can understand”, and received the following answer: “In short, the work of the Danish biotech company Curasight is about finding and irradiating aggressive cancer cells from within, so that healthy tissue is not damaged. Here are the most important technical terms translated into easily understandable language: The biological target uPAR (biomarker / receptor): A type of "antenna" or biological receiver located on the surface of aggressive cancer cells. Healthy cells largely do not have this antenna. Curasight uses this antenna as a homing address. Ligand (Peptide): A small, specially designed molecule (a protein part) that acts like a key. It can precisely lock onto the uPAR antenna on the cancer cell. The technology and methodTheranostics (Theranostics): A word composed of therapy (treatment) and diagnostics (examination). This means that the company uses exactly the same homing molecule to both visualize the cancer on a scanner and then treat it. Radionuclide therapy / Radioligand therapy (RLT): An integrated radiation treatment. A radioactive substance is attached to the homing molecule (the ligand) and injected into the bloodstream. It seeks out the cancer cells itself and destroys them with short-range radiation from within. PET scan (Positron Emission Tomography): An advanced imaging scan that shows the body's biological activity instead of just the physical organs. Curasight's specific productsuTRACE® (Diagnostics): Curasight's scanning method. Here, the homing molecule is coupled with a mild, radioactive tracer. This causes aggressive cancer tumors to "light up" on a PET scanner, so the doctor can see exactly how severe the cancer is. uTREAT® (Treatment): Curasight's treatment method. Here, the same homing molecule is reused, but now it is equipped with a much more powerful, radioactive substance. It functions as a homing missile that delivers radiation directly into the cancer cell without harming the surrounding healthy tissue.”
- ·22 t sittenI got a good tip - I thought - and bought, but with a drop of 17 k. it hasn't gone so well so far, and I think it's lying in a straight line and not really moving. Does anyone have an idea where the stock is going, or should I give up and sell?
- ·1 päivä sittenDoes anyone know if there is a Discord group with Curasight?·1 päivä sittenYes, it is here. https://discord.gg/XcsdMTJQtK
- ·2 päivää sittenHow heavily loaded are people here, unfortunately I only have 275 units so far 🫣
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Spotlight Stock Market DK
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 50 | NON | AVA | ||
| 131 | SSWM | NON | ||
| 618 | NRD | NON | ||
| 82 | NON | NON | ||
| 1 557 | DDB | NON |
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Danske Bank A/S | 2 000 | 600 | +1 400 | 0 |
| Nordea Bank Abp | 1 024 | 0 | +1 024 | 0 |
| Avanza Bank AB | 599 | 50 | +549 | 0 |
| SSW Market Making GmbH | 3 100 | 2 969 | +131 | 0 |
| Nordnet Bank AB | 22 167 | 25 271 | −3 104 | 18 548 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Nordnet Bank AB | 22 167 | 25 271 | −3 104 | 18 548 |
| SSW Market Making GmbH | 3 100 | 2 969 | +131 | 0 |
| Avanza Bank AB | 599 | 50 | +549 | 0 |
| Nordea Bank Abp | 1 024 | 0 | +1 024 | 0 |
| Danske Bank A/S | 2 000 | 600 | +1 400 | 0 |